Mechanical Function and Gene Expression of α1-Adrenoceptor Subtypes in Dog Intravesical Ureter

被引:8
作者
Kobayashi, Shinya [1 ]
Tomiyama, Yoshitaka
Hoyano, Yuji
Yamazaki, Yoshinobu
Kusama, Hiroshi
Kubota, Yasue
Sasaki, Shoichi
Kohri, Kenjiro
机构
[1] Kissei Pharmaceut Co Ltd, Pharmacol Res & Dev, Nagano 3998304, Japan
关键词
ALPHA-1-ADRENOCEPTOR SUBTYPES; SMOOTH-MUSCLE; ANTAGONIST; KMD-3213; STONES;
D O I
10.1016/j.urology.2009.01.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES To characterize the contractile functions and gene expression of the alpha(1)-adrenoceptor (AR) subtypes present in the dog intravesical ureter. METHODS In a functional Study, alpha(1)-AR antagonists were evaluated against phenylephrine (alpha(1)-AR agonist)-induced contractions in dog, isolated intravesical ureteral preparations. The quantitative expression of alpha(1)-AR Subtype mRNA in this tissue was determined using real-time quantitative reverse transcriptase-polymerase chain reaction, RESULTS In the isolated intravesical ureter, prazosin (nonselective alpha(1)-AR antagonist), silodosin (selective alpha(1A)-AR antagonist), naftopidil (selective alpha(1D)-AR antagonist), and BMY-7378 (selective alpha(1D)-AR antagonist) all shifted the concentration-contractile response curve for phenylephrine to the right. The rank order of potencies (pK(B) value) was silodosin (9-45 +/- 0.14), prazosin (8.16 +/- 0.08), naftopidil (7.39 +/- 0.19), and BMY-7378 (6.78 +/- 0.20), The alpha(1)-AR antagonist silodosin Was Much more potent than the 2 alpha(1D)-AR antagonists. The rank order of mRNA expression levels among the alpha(1)-AR subtypes was alpha(1d) (72.68%), alpha(1a) (24.14%), and alpha(1b), (3.18%). CONCLUSIONS In the clog intravesical ureter, alpha(1A)-AR plays a major role in contraction, despite the prevalence of alpha(1D)-AR. UROLOGY 74: 458-462, 2009. (C) 2009 Elsevier Inc.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 19 条
[1]  
Carstensen H E, 1973, Acta Chir Scand Suppl, V433, P66
[2]   Differences in the cellular localization and agonist-mediated internalization properties of the α1-adrenoceptor subtypes [J].
Chalothorn, D ;
McCune, DF ;
Edelmann, SE ;
García-Cazarín, ML ;
Tsujimoto, G ;
Piascik, MT .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :1008-1016
[3]   BMY-7378 IS A SELECTIVE ANTAGONIST OF THE D-SUBTYPE OF ALPHA(1)-ADRENOCEPTORS [J].
GOETZ, AS ;
KING, HK ;
WARD, SDC ;
TRUE, TA ;
RIMELE, TJ ;
SAUSSY, DL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (2-3) :R5-R6
[4]   Nonsurgical management of urolithiasis: An overview of expulsive therapy [J].
Healy, KA ;
Ogan, K .
JOURNAL OF ENDOUROLOGY, 2005, 19 (07) :759-767
[5]   NORADRENALINE MODULATES SMOOTH-MUSCLE ACTIVITY OF THE ISOLATED INTRAVESICAL URETER OF THE PIG THROUGH DIFFERENT TYPES OF ADRENOCEPTORS [J].
HERNANDEZ, M ;
PRIETO, D ;
SIMONSEN, U ;
RIVERA, L ;
BARAHONA, MV ;
GARCIASACRISTAN, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :924-931
[6]   Examination of alpha 1 adrenoceptor subtypes in the human ureter [J].
Itoh, Yasunori ;
Kojima, Yoshiyuki ;
Yasui, Takahiro ;
Tozawa, Keiichi ;
Sasaki, Shoichi ;
Kohri, Kenjiro .
INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (08) :749-753
[7]   Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? [J].
Küpeli, B ;
Irkilata, L ;
Gürocak, S ;
Tunç, L ;
Kiraç, M ;
Karaoglan, C ;
Bozkirli, I .
UROLOGY, 2004, 64 (06) :1111-1115
[8]  
MORITA T, 1994, NEUROUROL URODYNAM, V13, P315, DOI 10.1002/1520-6777(1994)13:3<315::AID-NAU1930130313>3.0.CO
[9]  
2-G
[10]   CHARACTERIZATION OF ALPHA-ADRENOCEPTOR SUBTYPES INVOLVED IN REGULATION OF URETERAL FLUID TRANSPORT [J].
MORITA, T ;
WADA, I ;
SUZUKI, T ;
TSUCHIDA, S .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 152 (02) :111-118